Publikationsdatum:
2016-09-08
Beschreibung:
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS) Leukemia 30, 1956 (September 2016). doi:10.1038/leu.2016.111 Authors: M Mossner, J-C Jann, D Nowak, U Platzbecker, A Giagounidis, K Götze, A Letsch, D Haase, K Shirneshan, F Braulke, R F Schlenk, T Haferlach, P Schafhausen, G Bug, M Lübbert, A Ganser, G Büsche, E Schuler, V Nowak, J Pressler, J Obländer, S Fey, N Müller, E Lauinger-Lörsch, G Metzgeroth, C Weiß, W-K Hofmann, U Germing & F Nolte
Print ISSN:
0887-6924
Digitale ISSN:
1476-5551
Thema:
Medizin
Permalink